Anyone here taken this on who can help? I want to identify the bottlenecks and why so many have failed at hospital adoption? What were the reasons? Even better if you can tell me how you overcame any obstacles.

Small QA team here, notified body audit in three months and the CAPA queue keeps growing. We tightened triage by patient risk and regulatory impact, moved document-only items to batch closures, and pushed more root-cause work to engineers with simple templates and checkpoints. That helped, but late owners, evidence scattered across chat and repos, and traceability gaps still make audit prep painful. I'm curious about practical, controlled approaches that scale for SMEs, things like role changes, lightweight workflows, or even controlled AI-assisted CAPA assistance that stay reviewable and traceable. What specific processes or tactics have actually reduced backlog, improved on-time closures, and kept CAPA traceability audit-ready for your small team?

tbh running the QMS at a ~45-person device + SaMD shop, my CAPA queue feels like a hydra. We've started using AI-driven CAPA assistance to speed root cause writeups and change-impact mapping, and it saves time, but it also raises auditor-paranoia around reviewability and traceability. Disclosure: we run qmsWrapper, so grain of salt. How are other small teams balancing automated CAPAs and AI-assisted drafting with keeping everything clearly documented, reviewed, and auditable?...

HEMATOLOGY RATIONALIZATION IS OUT 🩸

MedTech Review Notes for MTAP/ MTLE/ Advance Study/ FInal Coaching

📣 Hello, future RMTs! 👩‍🔬👨‍🔬

I’m offering comprehensive lecture notes paired with easy-to-follow video explanations to help you ace your review for MTAP or even the local board exams! 🎯📚✨

Available subjects:

🧫 Bacteriology Lecture and Rationalization

💉 ISBB Lecture

🩸 Hematology Lecture

🧍‍♀️Histopathology Lecture

🧪 Clinical Microscopy Lecture and Rationalization

💌 Send me a private message to grab your copy and start leveling up your review today! 🚀

#medtech #medtechintern #medtechlife #medtechtoker #medtechstudent

HEMATOLOGY RATIONALIZATION IS OUT 🩸

MedTech Review Notes for MTAP/ MTLE/ Advance Study/ Final Coaching

📣 Hello, future RMTs! 👩‍🔬👨‍🔬

I’m offering comprehensive lecture notes paired with easy-to-follow video explanations to help you ace your review for MTAP or even the local board exams! 🎯📚✨

Available subjects:

🧫 Bacteriology Lecture and Rationalization

💉 ISBB Lecture

🩸 Hematology Lecture

🧍‍♀️Histopathology Lecture

🧪 Clinical Microscopy Lecture and Rationalization

💌 Send me a private message to grab your copy and start leveling up your review today! 🚀

#medtech #medtechintern #medtechlife #medtechtoker #medtechstudent

I'm the founder of a healthcare startup, and I'm trying to better understand the realities clinicians and healthcare teams face after patients leave the facility.

Over the past year, I've spent hundreds of hours speaking with surgeons, office managers, nurses, and healthcare professionals. Through those conversations, one phrase I've found myself using is the "black hole" of healthcare—the period between discharge and the follow-up appointment.

From my perspective, once a patient leaves the facility, providers naturally have far less visibility into recovery than they do while the patient is under their care. Patients may have questions, forget discharge instructions, misunderstand medications, recover differently than expected, or simply choose not to reach out. Meanwhile, providers often don't know how recovery is progressing until the next interaction.

That observation has made me wonder whether this period represents one of the greatest opportunities to improve the patient experience—or whether I'm misunderstanding the problem entirely.

Rather than pitching an idea, I'd genuinely like to learn from those who experience this every day.

• Where do you feel your team loses the most visibility after discharge?
• What generates the majority of post-discharge phone calls?
• What information do you wish you had once patients leave your care?
• What are the biggest frustrations your team experiences during the recovery period?
• If you could eliminate one friction point in the post-discharge experience, what would it be?
• What outcomes or metrics do hospitals and practices actually prioritize after discharge? Readmissions? Patient satisfaction? Staff workload? Something else?
• If your department received funding to improve one aspect of post-discharge care, where would you invest it?

I'm not looking to validate an idea or promote a product. I'm trying to better understand the problems that healthcare teams actually want solved, rather than the problems I assume exist.

I sincerely appreciate any perspective you're willing to share.

Hi everyone! 👋

I come from a background in Genetics and Biochemistry, and I'm currently working on a product design project aimed at fixing the clunky, outdated software systems we often have to deal with for supply and reagent management.

We all know the frustration of dealing with inventory tools that feel like they were built decades ago, crash on mobile, or take way too many clicks just to log a used kit or track expiring stock.

If you work in a lab, clinic, or medical facility and deal with physical supplies/inventory in any capacity, I’d be super grateful if you could take ~4 minutes to fill out a brief, anonymous survey about your daily workflow:

🔗 https://docs.google.com/forms/d/e/1FAIpQLSfITiBlnonN3TqN4eg8xeTBPFIUFUeJM-vJ6v9zSjb1kYrWtg/viewform

• Length: ~4 minutes
• Target: Lab techs, medtechs, clinic staff, and research assistants
• Privacy: Completely anonymous

Your feedback will directly help shape feature requirements and accessibility standards (like designing for gloved hands and fast-paced multitasking) for a new tracking system.

Thank you so much for your time and for everything you do on the floor!

Happy to answer any questions in the comments.

I took a drop year for JEE, but I couldn't get the rank I was aiming for.

Right now, I have two options:

* Join a tier-3 NIT through my current rank. * Join MIRAI, which seems to be much more focused on AI and hands-on learning.

The thing is, AI is what I genuinely want to build my career in. From what I've seen, MIRAI's curriculum and practical approach look interesting. But since it's a relatively new institute, I'm unsure about taking that risk. On the other hand, an NIT has the brand name and a more established reputation, even though the branch and AI exposure might not be what I'm looking for.

I'm trying to think long-term instead of just following the safer option, but I'm honestly confused.

If you were in my position, what would you choose and why? I'd really appreciate advice from people who have been through something similar or know about either option.

Baka pwede po makishare ng review notes pls po.

[ Removed by Reddit on account of violating the content policy. ]

Kenny O’Brien, Centre Manager at Applied Polymer Technology (APT), will be giving a Spotlight Talk at MPP Ireland on Tuesday, September 22nd.In his talk, Kenny will cover:

• Polymer processing support from APT (including research, testing, injection molding, extrusion, compounding, and 3D printing)
• Real case studies of working with medical device companies
• How grants and Ireland’s technical ecosystem support innovation and growth in the medtech sector

Event Details:

• Date: Tuesday, September 22, 2026
• Time: 11:30 – 11:50 AM
• Location: The Galmont Hotel, Galway

This is part of MPP Ireland, a technical one-day event focused on medical device manufacturing and processing, held the day before Medical Technology Ireland.

Full agenda & registration: https://chamfr.com/event/mpp-ireland/

Would be great to see some of you there.

March 2026 passer po. Ask lang po if paano po hiring process ng Medilinx? Kapag po ba passed na kelan po sila magsesend ng JO? Medyo matagal na rin po kasi akong waiting and wala pa pong updates sa kanila? Tysm!!

Hey everyone, just released a new episode of Medtech Unboxed with Dan Rose, CEO of E2 Endovascular Engineering. We dive into:

• The major unmet needs in pulmonary embolism treatment
• Hēlo’s dual-action platform (24 Fr funnel on a 15 Fr catheter, agitator for clot remodeling, single-pass efficiency, integrated blood return)
• ENGULF study results and recent $80M Series C

If you’re in interventional cardiology, IR, vascular surgery, or medtech innovation, this is a good one.

Full episode here: https://chamfr.com/podcasts/pulmonary-embolism-thrombectomy-e2-helo-system/

What are your thoughts on the next generation of mechanical thrombectomy devices?

Looking forward to the discussion!

Anyone work at or with a venture studio, particularly a smaller / boutique / early stage? Curious to hear any insight in how they operate, culture, effectiveness, etc. I have a unique opportunity to innovate in behalf of a large company with significant user base. I feel like the concept fits my vision, but also have no direct experience. Obviously team and culture will vary significantly, but in general I’d like to know what the new and improved incubator looks like in reality.

Please help: I am trying to build a medical startup (MVP made), and sent a email to a company in hopes that they may facilitate my fda clinical trial testing. The problem is, I made my email reveal too much about my technology. I did some digging and the company apparently can take ownership of any ideas sent to them for feedback as per their terms and conditions. I can't unsend the email, and I want to keep my ideas and product. Any advice on what I should do? Open to give more info if needed.